关于公司
SciGen Israel is a high growth biopharmaceutical company that develops, manufactures and markets recombinant human health care biotechnology derived products. SciGen Israel manufacture all stages of 3rd generation Hepatitis B vaccine from thawing of working cell bank through production, purification, formulation, filling, QC testing packaging and marketing. SciGen Israel has created its own research and development centre in order to focus on bacteria (E.coli) and mammalian cell (CHO cell) technology. At SciGen’s R&D centre continued advancement of its current molecules and other R&D activities are ongoing.
IT
未知
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论